Method validation of (E)-4-(3', 4'-dimethoxyphenyl)-but-3-en-1-ol in Zingiber cassumunar Roxb. with different extraction techniques

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 3, 2014, Pages 295-298

  Suksaeree, Jirapornchai ^a   Madaka, Fameera ^a   Monton, Chaowalit ^a   Sakunpak, Apirak ^a   Chusut, Tun ^a   Charoonratana, Tossaton ^a  

^a RANGSIT UNIVERSITY   (Thailand)

Author keywords

(E) 4 (3',4' dimethoxyphenyl) but 3 en 1 ol; Compound D; HPLC; Method validation; Zingiber cassumunar Roxb

Indexed keywords

4 (3, 4 DIMETHOXYPHENYL) BUT 3 EN 1; PLANT EXTRACT; UNCLASSIFIED DRUG; ZINGIBER MONTANUM EXTRACT;

ACCURACY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; CORRELATION COEFFICIENT; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY; VALIDATION PROCESS; ZINGIBER MONTANUM;

EID: 84898472752     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kanjanapothi D, Soparat P, Panthong A, Tuntiwachwuttikul P, Reutrakul V. A uterine relaxant compound from Zingiber cassumunar. Planta Med 1987; 53: 329-32.
2. Panthong A, Kanjanapothi D, Niwatananant W, Tuntiwachwuttikul P, Reutrakul V. Anti-inflammatory activity of compound D {(E)-4-(3',4'-dimethoxyphenyl)but-3-en-2-ol} isolated from Zingiber cassumunar Roxb. Phytomedicine 1997; 4(3): 207-12.
3. Panthong A, Kanjanapothi D, Niwatananun V, Tuntiwachwuttikul P, Reutrakul V. Anti-inflammatory activity of compounds isolated from Zingiber cassumunar. Planta Med 1990; 56(6): 655.
4. Ozaki Y, Kawahara N, Harada M. Anti-inflammatory effect of Zingiber cassumunar Roxb. and its active principles. Chem Pharm Bull (Tokyo) 1991; 39(9): 2353-59.
5. Pithayanukul P, Tubprasert J, Wuthi-Udomlert M. In Vitro antimicrobial activity of Zingiber cassumunar (Plai) oil and a 5% Plai oil gel. Phytother Res 2007; 21(2): 164-69.
6. Pongprayoon U, et al. Topical antiinflammatory activity of the major lipophilic constituents of the rhizome of Zingiber cassumunar. Part I: The essential oil. Phytomedicine 1997; 3(4): 319-22.
7. Pongprayoon U, et al. Topical antiinflammatory activity of the major lipophilic constituents of the rhizome of Zingiber cassumunar. Part II: Hexane extractives. Phytomedicine 1997; 3(4): 323-26.
8. Panomhom R, Thiengkamol N, Thiengkamol T, Kurukod J. A study of knowledge, practice and satisfaction of herbal compressed ball use through workshop for health volunteer. Eur J Soc Sci 2012; 31(4): 550-57.
9. Suksaeree J, Charoenchai L, Pichayakorn W, Boonme P. HPLC method development and validation of (E)-4-(3,4-dimethoxyphenyl)-but-3-en-1-ol in Zingiber cassumunar Roxb. from Thai Herbal Compress ball. Int J Pharm Pharm Sci Res 2013; 3(3): 115-17.
10. Arun RR. Formulation evaluation and in vitro permeation studies of transdermal nifedipine from matrix types patches. Int J Pharm Pharm Sci 2014; 6(1): 185-88.
11. ICH, Guidance for industry; Q2B Validation of analytical procedures: methodology1996, Maryland: U.S. Department of Health and Human Service.
12. Chairul P, Chairul SM. Phagocytosis effectivity test of phenylbutenoid compounds isolated from bangle (Zingiber cassumunar Roxb.) rhizome. Biodiversitas 2009; 10(1): 40-43.